Insulin pathway related genes and risk of colorectal cancer: INSR promoter polymorphism shows a protective effect

Endocrine-Related Cancer

Volumn 14, Issue 3, 2007, Pages 733-740

  Pechlivanis, Sonali ^a   Pardini, Barbara ^b,c   Bermejo, Justo Lorenzo ^a   Wagner, Kerstin ^a   Naccarati, Alessio ^b   Vodickova, Ludmila ^b,d   Novotny, Jan ^e   Hemminki, Kari ^a,f   Vodicka, Pavel ^b   Försti, Asta ^a,f  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^c UNIVERSITY OF PISA   (Italy)

^d NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^e CHARLES UNIVERSITY   (Czech Republic)

^f KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; SOMATOMEDIN BINDING PROTEIN 1; TRANSCRIPTION FACTOR SP1;

ADULT; AGED; ARTICLE; BINDING SITE; CANCER RISK; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; PROTEIN FUNCTION; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CARCINOMA; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN; MALE; MIDDLE AGED; PHOSPHOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RECEPTOR, INSULIN; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 35948978953     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-07-0107     Document Type: Article

References (28)

1. Almind K, Inoue G, Pedersen O & Kahn CR 1996 A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. Journal of Clinical Investigation 97 2569-2575.
2. Araki E, Murakami T, Shirotani T, Kanai F, Shinohara Y, Shimada F, Mori M, Shichiri M & Ebina Y 1991 A cluster of four Sp1 binding sites required for efficient expression of the human insulin receptor gene. Journal of Biological Chemistry 266 3944-3948.
3. Bennett ST & Todd JA 1996 Human type 1 diabetes and the insulin gene: principles of mapping polygenes. Annual Review of Genetics 30 343-370.
4. Biddinger SB & Kahn CR 2006 From mice to men: insights into the insulin resistance syndromes. Annual Review of Physiology 68 123-158.
5. Calle EE & Kaaks R 2004 Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Reviews. Cancer 4 579-591.
6. de la Chapelle A 2004 Genetic predisposition to colorectal cancer. Nature Reviews. Cancer 4 769-780.
7. Cheng I, Penney KL, Stram DO, Le Marchand L, Giorgi E, Haiman CA, Kolonel LN, Pike M, Hirschhorn J, Henderson BE et al. 2006 Haplotype-based association studies of IGFBPI and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort. Cancer Epidemiology, Biomarkers and Prevention 15 1993-1997.
8. Claeys GB, Sarma AV, Dunn RL, Zuhlke KA, Beebe-Dimmer J, Montie JE, Wojno KJ, Schottenfeld D & Cooney KA 2005 INSPstI polymorphism and prostate cancer in African-American men. Prostate 65 83-87.
9. Foti D, Iuliano R, Chiefari E & Brunetti A 2003 A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin receptor gene transcription. Molecular and Cellular Biology 23 2720-2732.
10. Giovannucci E 2001 Insulin, insulin-like growth factors and colon cancer: a review of the evidence. Journal of Nutrition 131 3109S-3120S.
11. Gunter MJ, Hayes RB, Chatterjee N, Yeager M, Welch R, Schoen RE, Yakochi L, Schatzkin A & Peters U 2007 Insulin resistance-related genes and advanced left-sided colorectal adenoma. Cancer Epidemiology, Biomarkers and Prevention 16 703-708.
12. Haruta T, Imamura T, Iwanishi M, Egawa K, Goji K & Kobayashi M 1995 Amplification and analysis of promoter region of insulin receptor gene in a patient with leprechaunism associated with severe insulin resistance. Metabolism 44 430-437.
13. Ho GY, Melman A, Liu SM, Li M, Yu H, Negassa A, Burk RD, Hsing AW, Ghavamian R & Chua SC Jr 2003 Polymorphism of the insulin gene is associated with increased prostate cancer risk. British Journal of Cancer 88 263-269.
14. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE & Riboli E 2000 Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. Journal of National Cancer Institute 92 1592-1600.
15. Kadonaga JT, Jones KA & Tjian R 1986 Promoter-specific activation of RNA polymerase II transcription by Sp1. Trends in Biochemical Sciences 11 20-23.
16. Kadowaki T, Kadowaki H, Rechler MM, Serrano-Rios M, Roth J, Gorden P & Taylor SI 1990 Five mutant alleles of the insulin receptor gene in patients with genetic forms of insulin resistance. Journal of Clinical Investigation 86 254-264.
17. LeRoith D & Roberts CT Jr 2003 The insulin-like growth factor system and cancer. Cancer Letters 195 127-137.
18. Li L, Cicek MS, Casey G & Witte JS 2005 No association between genetic polymorphisms in insulin and insulin receptor substrate-1 and prostate cancer. Cancer Epidemiology, Biomarkers and Prevention 14 2462-2463.
19. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A & Hemminki K 2000 Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. New England Journal of Medicine 343 78-85.
20. Neuhausen SL, Slattery ML, Garner CP, Ding YC, Hoffman M & Brothman AR 2005 Prostate cancer risk and IRS1, IRS2, IGFI, and INS polymorphisms: strong association of IRS1 G972R variant and cancer risk. Prostate 64 168-174.
21. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF & Moore JH 2001 Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. American Journal of Human Genetics 69 138-147.
22. Sandhu MS, Dunger DB & Giovannucci EL 2002 Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. Journal of National Cancer Institute 94 972-980.
23. Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, Tracy RP, Dobs A & Savage PJ 1999 Increased blood glucose and insulin, body size, and incident colorectal cancer. Journal of National Cancer Institute 91 1147-1154.
24. Slattery ML, Samowitz W, Curtin K, Ma KN, Hoffman M, Caan B & Neuhausen S 2004 Associations among IRS1, IRS2, IGFI, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiology, Biomarkers and Prevention 13 1206-1214.
25. Stephens RH, McElduff P, Heald AH, New JP, Worthington J, Ollier WE & Gibson JM 2005 Polymorphisms in IGF-binding protein 1 are associated with impaired renal function in type 2 diabetes. Diabetes 54 3547-3553.
26. Wagner K, Hemminki K, Grzybowska E, Klaes R, Butkiewicz D, Pamula J, Pekala W, Zientek H, Mielzynska D, Siwinska E et al. 2004 The insulin-like growth factor-I pathway mediator genes: SHC1 Met300Val shows a protective effect in breast cancer. Carcinogenesis 25 2473-2478.
27. Wagner K, Hemminki K & Forsti A 2007 The GH1/IGF-1 axis polymorphisms and their impact on breast cancer development. Breast Cancer Research Treatment 104 233-248.
28. Yoshizato K, Shirotani T, Furukawa N, Taguchi T, Motoshima H, Toyonaga T, Hirashima Y, Kawashima J, Ebina Y, Shichiri M et al. 2001 Identification of a cis-acting element and a novel trans-acting factor of the human insulin receptor gene in HepG2 and rat liver cells. Biochemical and Biophysical Research Communications 280 428-434.